Association between the use of antipsychotics and risk of breast cancer The long-term use (cDDD ≥ 365) of SGAs (OR: 0.8) and FGAs (OR: 0.72) showed a trend towards a decreased risk of breast cancer, while the short-term use (30–179) of SGAs overall, olanzapine, risperidone, and chlorpromazine was significantly associated with a decreased risk of breast cancer.
← all excerpts
Exposure to psychotropic drugs and breast cancer risk in patients with bipolar disorder and major depressive disorder: a nested case-control study.
1
—
—